Meeting
2012 Gastrointestinal Cancers Symposium
Accelerated fraction radiotherapy with concomitant capecitabine as neoadjuvant therapy of borderline resectable pancreatic cancer.
Authors
Samhita Chakraborty
University of Virgnia Health System, Charlottesville, VA
Samhita Chakraborty , Todd W. Bauer , Monica M Morris , Erin Yarde , J Thomas Parsons , Reid B Adams , Hanna Kelly Sanoff
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Multidisciplinary Treatment
Clinical Trial Registration Number
NCT01333332
Citation
J Clin Oncol 30, 2012 (suppl 4; abstr 329)
DOI
10.1200/jco.2012.30.4_suppl.329
Abstract #
329
Poster Bd #
E13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
A phase I study of oral live biotherapeutic MRx0518 with hypofractionated preoperative radiation for resectable pancreatic cancer.
First Author: Cullen M. Taniguchi
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Prospective evaluation of dose-escalated preoperative concurrent chemo-radiation with image-guided intensity modulated radiation therapy in locally advanced rectal cancers.
First Author: Raunaq Puri
Poster
2013 Gastrointestinal Cancers Symposium
Efficacy and feasibility of chemotherapy and radiation therapy for borderline resectable pancreatic cancer in elderly patients.
First Author: Nicholas Figura
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Neoadjuvant SBRT plus regional nodal irradiation with concurrent capecitabine for patients with resectable pancreatic cancer: Survival analysis of prospective phase 1 trial.
First Author: Mustafa Basree